SCWorx Corp.

As of May 15, 2017, SCWorx Corp. is considered overvalued and risky due to poor financial ratios and significant underperformance, with a year-to-date return of -82.16% compared to the S&P 500's 12.22%.

As of May 15, 2017, SCWorx Corp. is considered overvalued with a "risky" rating, reflected in its poor financial metrics, including a Price to Book Value of 0.32, an EV to Sales ratio of 0.27, a ROCE of -30.81%, and a year-to-date return of -74.85%, significantly underperforming the S&P 500.

As of June 2, 2025, the technical trend has shifted to a bearish stance, driven by daily moving averages, monthly RSI, and Bollinger Bands, despite some mildly bullish signals from the weekly MACD and KST.

SCWorx Corp. provides software solutions for healthcare providers' business management and is classified as a micro-cap company with a market cap of $1.62 million. As of March 2025, it reported net sales of $1 million and no net profit.

As of Jun 18, SCWorx Corp. has a market capitalization of 1.62 million, with net sales of 2.90 million and a net profit of -1.44 million over the latest four quarters. As of Dec 24, shareholder's funds are 4.49 million and total assets are 6.35 million.